David Fuller
Chief Tech/Sci/R&D Officer at DIMERIX LIMITED
Net worth: 1 548 $ as of 29/04/2024
David Fuller active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ADALTA LIMITED | Director/Board Member | 21/07/2020 | - |
| DIMERIX LIMITED | Chief Tech/Sci/R&D Officer | 22/10/2023 | - |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Chairman | - | - |
Career history of David Fuller
Former positions of David Fuller
| Companies | Position | Start | End |
|---|---|---|---|
| RACE ONCOLOGY LIMITED | Chief Tech/Sci/R&D Officer | 30/06/2021 | 10/11/2022 |
Statistics
International
| Australia | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ADALTA LIMITED | Health Technology |
| RACE ONCOLOGY LIMITED | Health Technology |
| DIMERIX LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
- Stock Market
- Insiders
- David Fuller
- Experience
